NMTR Annual EBIT
-$41.10 M
-$4.37 M-11.89%
31 December 2022
Summary:
As of February 5, 2025, NMTR annual earnings before interest & taxes is -$41.10 million, with the most recent change of -$4.37 million (-11.89%) on December 31, 2022. During the last 3 years, it has fallen by -$15.88 million (-62.94%).NMTR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTR Quarterly EBIT
-$13.12 M
-$3.01 M-29.73%
31 March 2023
Summary:
As of February 5, 2025, NMTR quarterly earnings before interest & taxes is -$13.12 million, with the most recent change of -$3.01 million (-29.73%) on March 31, 2023. Over the past year, it has dropped by -$1.76 million (-15.54%).NMTR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTR TTM EBIT
-$42.86 M
-$1.76 M-4.29%
31 March 2023
Summary:
As of February 5, 2025, NMTR TTM earnings before interest & taxes is -$42.86 million, with the most recent change of -$1.76 million (-4.29%) on March 31, 2023. Over the past year, it has dropped by -$166.60 thousand (-0.39%).NMTR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NMTR EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.9% | -15.5% | -0.4% |
| 3 y3 years | -62.9% | -332.9% | -76.8% |
| 5 y5 years | -268.0% | -16.1% | -69.9% |
NMTR EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +1121.4% | -5104.0% | +3601.5% |
9 Meters Biopharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$13.12 M(+29.7%) | -$42.86 M(+4.3%) |
| Dec 2022 | -$41.10 M(+11.9%) | -$10.11 M(+18.8%) | -$41.10 M(+1.4%) |
| Sept 2022 | - | -$8.51 M(-23.6%) | -$40.54 M(-11.0%) |
| June 2022 | - | -$11.13 M(-1.9%) | -$45.57 M(+6.7%) |
| Mar 2022 | - | -$11.35 M(+18.8%) | -$42.70 M(+16.2%) |
| Dec 2021 | -$36.73 M(-36.1%) | -$9.55 M(-29.4%) | -$36.73 M(+15.5%) |
| Sept 2021 | - | -$13.54 M(+64.1%) | -$31.80 M(+29.9%) |
| June 2021 | - | -$8.25 M(+53.2%) | -$24.48 M(-59.1%) |
| Mar 2021 | - | -$5.39 M(+16.4%) | -$59.81 M(+4.1%) |
| Dec 2020 | -$57.45 M(+127.8%) | -$4.63 M(-25.5%) | -$57.45 M(-6.2%) |
| Sept 2020 | - | -$6.21 M(-85.7%) | -$61.23 M(-4.0%) |
| June 2020 | - | -$43.58 M(+1338.2%) | -$63.77 M(+163.0%) |
| Mar 2020 | - | -$3.03 M(-64.0%) | -$24.25 M(-3.9%) |
| Dec 2019 | -$25.22 M(+40.1%) | -$8.41 M(-3.9%) | -$25.22 M(+23.2%) |
| Sept 2019 | - | -$8.75 M(+115.7%) | -$20.47 M(+78.7%) |
| June 2019 | - | -$4.06 M(+1.2%) | -$11.45 M(+6.9%) |
| Mar 2019 | - | -$4.01 M(+9.7%) | -$10.72 M(-40.5%) |
| Dec 2018 | -$18.01 M | -$3.65 M(-1493.7%) | -$18.01 M(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $262.10 K(-107.9%) | -$16.58 M(-13.6%) |
| June 2018 | - | -$3.32 M(-70.6%) | -$19.18 M(+3.4%) |
| Mar 2018 | - | -$11.30 M(+408.6%) | -$18.55 M(+66.1%) |
| Dec 2017 | -$11.17 M(+107.4%) | -$2.22 M(-5.1%) | -$11.17 M(+9.6%) |
| Sept 2017 | - | -$2.34 M(-13.0%) | -$10.19 M(+5.5%) |
| June 2017 | - | -$2.69 M(-31.3%) | -$9.66 M(+22.7%) |
| Mar 2017 | - | -$3.92 M(+214.6%) | -$7.87 M(+41.0%) |
| Dec 2016 | -$5.39 M(-26.8%) | -$1.25 M(-31.1%) | -$5.58 M(-16.1%) |
| Sept 2016 | - | -$1.81 M(+100.6%) | -$6.66 M(+6.6%) |
| June 2016 | - | -$901.00 K(-44.7%) | -$6.24 M(-2.4%) |
| Mar 2016 | - | -$1.63 M(-29.8%) | -$6.40 M(-13.1%) |
| Dec 2015 | -$7.36 M(-21.6%) | -$2.32 M(+66.6%) | -$7.36 M(-39.5%) |
| Sept 2015 | - | -$1.39 M(+31.7%) | -$12.17 M(+2.0%) |
| June 2015 | - | -$1.06 M(-59.2%) | -$11.93 M(+9.7%) |
| Mar 2015 | - | -$2.59 M(-63.7%) | -$10.88 M(+31.3%) |
| Dec 2014 | -$9.38 M(+178.8%) | -$7.13 M(+515.6%) | -$8.29 M(+615.6%) |
| Sept 2014 | - | -$1.16 M | -$1.16 M |
| Dec 2013 | -$3.37 M | - | - |
FAQ
- What is 9 Meters Biopharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for 9 Meters Biopharma?
- What is 9 Meters Biopharma annual EBIT year-on-year change?
- What is 9 Meters Biopharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for 9 Meters Biopharma?
- What is 9 Meters Biopharma quarterly EBIT year-on-year change?
- What is 9 Meters Biopharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for 9 Meters Biopharma?
- What is 9 Meters Biopharma TTM EBIT year-on-year change?
What is 9 Meters Biopharma annual earnings before interest & taxes?
The current annual EBIT of NMTR is -$41.10 M
What is the all time high annual EBIT for 9 Meters Biopharma?
9 Meters Biopharma all-time high annual earnings before interest & taxes is -$3.37 M
What is 9 Meters Biopharma annual EBIT year-on-year change?
Over the past year, NMTR annual earnings before interest & taxes has changed by -$4.37 M (-11.89%)
What is 9 Meters Biopharma quarterly earnings before interest & taxes?
The current quarterly EBIT of NMTR is -$13.12 M
What is the all time high quarterly EBIT for 9 Meters Biopharma?
9 Meters Biopharma all-time high quarterly earnings before interest & taxes is $262.10 K
What is 9 Meters Biopharma quarterly EBIT year-on-year change?
Over the past year, NMTR quarterly earnings before interest & taxes has changed by -$1.76 M (-15.54%)
What is 9 Meters Biopharma TTM earnings before interest & taxes?
The current TTM EBIT of NMTR is -$42.86 M
What is the all time high TTM EBIT for 9 Meters Biopharma?
9 Meters Biopharma all-time high TTM earnings before interest & taxes is -$1.16 M
What is 9 Meters Biopharma TTM EBIT year-on-year change?
Over the past year, NMTR TTM earnings before interest & taxes has changed by -$166.60 K (-0.39%)